Study title:
PET and PET/CT in Pediatric Oncology.Semin Nucl Med 37:316-331. Hossein Jadvar, MD, PhD, MPH, MBA,* Leonard P. Connolly, MD,†
Frederic H. Fahey, DSc,† and Barry L. Shulkin, MD, MBA‡
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Steripet |
ATC code: |
Document link:
jadvar-2007.pdf
|
Document date: 2014-12-02
|
Study number: |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|